CureVac IPO Stands Out, Stock 3.5 times on the First Day of Trading

Germany-based biopharma company CureVac B.V. (CVAC) recently went public, selling nearly 13 million shares of its common stock at $16 a share. The company successfully raised approximately $213 in gro...